There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Edwards Lifesciences Corporation (EW) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$2.02, or -2.32%, to $85.17. Volume reached 150,939 shares, with price reaching a high of $86.47 and a low of $85. Earlier, Yahoo Finance discussed this stock as it revealed EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL.
As a NYSE listed company, EW falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $85.22 and fluctuated between $88.68 as its day high and $85.18 as its day low. The current market capitalization of Edwards Lifesciences Corporation is $53.70B. A total of 2.14 million shares were traded on the day, compared to an average of 2.56M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, EW has seen 11 BUY and 16 SELL insider trades, representing the acquisition of 117,491 and the disposition of 96,170 shares. Over the last 12 months, there were 99 BUYs and 167 SELLs from insiders. Insiders purchased 1,261,418 shares during that period but sold 1,001,785.
In the most recent transaction, BOBO DONALD E JR sold 6,725 shares of EW for 90.94 per share on Sep 08. After the transaction, the CVP,Strategy/Corp Development now owns 62,561 company shares. In a previous transaction on Sep 06, Wood Larry L sold 7,242 shares at 89.00 per share. EW shares that CVP, TAVR owns now total 202,232.
Among the insiders who sold shares, MUSSALLEM MICHAEL A disposed of 19,875 shares on Aug 15 at a per-share price of $104.74. This resulted in the Chairman & CEO holding 157,353 shares of EW after the transaction. In another insider transaction, Zovighian Bernard J sold 4,811 shares at $103.66 per share on Aug 05. Company shares held by the CVP, TMTT now total 21,247.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $116.58 with high estimates of $130.00 and low estimates of $97.00. In terms of 52-week highs and lows, EW has a high of $131.73 and a low of $85.58.
As of this writing, EW has an earnings estimate of $0.62 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $0.64 per share and a lower estimate of $0.61.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Sell with a score of 4.53. A total of 15 analysts rated the stock as Buy while 2 rated it as Overweight while 6 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.